MedTrace Logo

Autologous Stem Cells for Urinary Incontinence: Single Patient Compassionate Use

NCT01648491 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2017-01-10

Study results available
· View outcomes & findings →

Summary

Determine safety and effectiveness of the technique using autologous stem cells in the treatment of urinary incontinence in one male subject.

Conditions

  • Stress Urinary Incontinence

Interventions

PROCEDURE

Muscle Biopsy

Biopsy of thigh muscle to obtain stem cell core.

BIOLOGICAL

Injection of autologous stem cells

After autologous stem cells have multiplied over 6 weeks time they are injected into the subjects urethra.

Sponsors & Collaborators

  • William Beaumont Hospitals

    collaborator OTHER

  • Kenneth Peters, MD

    lead OTHER

Principal Investigators

  • Kenneth M Peters, MD · William Beaumont Hospitals

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
78 Years
Max Age
82 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-07-31
Completion
2016-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01648491 on ClinicalTrials.gov